Based in Virginia, Maryland and Washington, DC, SCANR is composed of 7 regional hospitals: MedStar Washington Hospital Center, MedStar National Rehabilitation Hospital, MedStar Georgetown University Hospital, Children’s National Medical Center, University of Virginia, University of Maryland, and the Baltimore VA Medical Center.

In 2016, SCANR sites evaluated over 4100 acute strokes with over 50% Black/African American. SCANR includes four Carnegie Research 1 universities (Georgetown, George Washington Universities, and the Universities of Virginia and Maryland), two CTSA’s, a translational research institute (THRIV), a US News & World Report National Honor Roll Hospital (CNMC), the largest hospital in DC (MWHC) and the NINDS Intramural Stroke Program.

SCANR research expertise also includes multimodal imaging, microbiomics, multi-omics, neurorehabilitation trials, brain stimulation, and robotics. We are well positioned to translate early phase NINDS intramural studies into the extramural setting. We have a track record of recruiting substantial numbers of specific cerebrovascular phenotypes including cervical artery dissection, cerebral venous thrombosis, cerebral amyloid angiopathy, etc.